Transdermal Continuous Glucose Monitoring System
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Transdermal Continuous Glucose Monitoring System, covering 2025-03-10 to 2025-03-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate a Transdermal Continuous Glucose Monitoring System in Diabetic Patients for a Period of 28 Days [NA]